{"id":"5d88c1315a9e","type":"article","url":"https://hartvaat.nl/2018/12/18/2018-acc-expert-consensus-nieuwe-therapieen-voor-cv-risicoreductie-bij-diabetes-/","title":"2018 ACC Expert Consensus: nieuwe therapieën voor CV-risicoreductie bij diabetes type 2","title_en":"2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways.","category":"preventie","category_label":"Preventie","professions":["apotheker","cardioloog","huisarts","internist"],"tags":[],"journal":"Journal of the American College of Cardiology","doi":"10.1016/j.jacc.2018.09.020","source_url":"https://doi.org/10.1016/j.jacc.2018.09.020","authors":["Sandeep R Das","Brendan M Everett","Kim K Birtcher","Jenifer M Brown","William T Cefalu","James L Januzzi","Rita Rastogi Kalyani","Mikhail Kosiborod","Melissa L Magwire","Pamela B Morris","Laurence S Sperling"],"significance":9,"published":"2018-12-18","source_date":"2018-12-18","image":"","kennis":["https://hartvaat.nl/kennis/preventie/preventie-bij-diabetes/","https://hartvaat.nl/kennis/cardiometabool/diabetes-type-1-en-hart/"],"congress":"","summary_en":"The 2018 ACC Expert Consensus provided the first integrated decision pathway for using SGLT2 inhibitors and GLP-1 receptor agonists for cardiovascular risk reduction in patients with type 2 diabetes and established atherosclerotic disease, heart failure, or chronic kidney disease.","created":"2026-07-03T10:27:40Z","updated":"2026-07-03T13:26:53Z","licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies.","body_markdown":"ACC 2018 expert consensus over nieuwe therapieën (SGLT2-remmers, GLP-1-agonisten) voor cardiovasculaire risicoreductie bij diabetes type 2. Eerste integratie in practice pathway.","abstract_original":""}